CARRAGEENAN & FURCELLARAN Explanation These substances have been evaluated for acceptable daily intake by the Joint FAO/WHO Expert Committee on Food Additives in 1969 and 1974. New data on carrageenan have become available and are summarized in the present monograph. Native carrageenan is a mixture of highly sulfated polygalactosides and is extracted from seaweeds. The detailed structure varies slightly between samples depending on the source but all samples have a sulfate/galactoside ratio of approximately one and a molecular weight of 800 000 to one million. Native carrageenan is used by the food and toiletry industry. Degraded carrageenan is prepared from the extract of Eucheuma spinosum by partial hydrolysis, using dilute HC1, followed by purification. The sulfate/galactoside ratio is the same as in native form but the molecular weight is only 20 000. This material is not used by food manufacturers but is sold as an antipeptic agent on the continent. It has, however, been used as a model compound in many of the investigations into the mechanism of action of native carrageenan since it produces the same lesion in guinea pigs as the native form but much more rapidly and consistently. Furcellaran is derived from the other varieties of seaweeds and has not been tested as such. However, it belongs chemically to the general range of carrageenan and carrageenan-like substances. Degradation of carrageenan Some researchers have noted the possibility of degradation of native carrageenan in the gut. This possibility seems to be of limited toxicological significance for, if native carrageenan were sufficiently degraded in the gut to cause ulceration or tumor growth, then the feeding studies would have shown it. Since food grade carrageenan does not have the same effects as degraded carrageenan, it is either not degraded, not degraded to the same molecular weight, or not degrated in the same way. The evidence we have so far is that it is only partly degraded, that most of the degradation takes place in the stomach and that this limited degradation has no effect on the gut wall. In the stomach where pH is very low, acid hydrolysis undoubtedly does occur. In vitro experiments with a kappa-lambda mixture in simulated gastric juice at pH 1.2 and 37°C showed that in three hours the breakdown of glycosidic linkages was less than 0.1% (Stancioff et al., 1975). Ekstrom & Kuivinen (1983) recently reported a breakdown for kappa carrageenan that was about 15 times greater. Furthermore, they hydrolyzed for six hours at pH 1.0 - rather drastic conditions unlikely to occur normally in the stomach. In a full stomach the pH would be expected to be considerably higher. There is currently no evidence that carrageenan is degraded in the lower gut. Incubation of a carrageenan solution with the cecal contents of rats for several hours at 37°C did not alter its viscosity, which indicates that the microbial flora, of the rat gut at any rate, will not break down carrageenan (Grasso et al., 1973). Ochuba & Ven Riesen (1980) reported in vitro degradation of carrageenan by a large number of intestinal bacteria but their results are not valid because the carrageenan they used contained 20% reducing sugar which would have given a positive result in their test method. Among the bacteria they claimed would break down carrageenan were Kelbsiella pneumonia and Escherichia coli. However, both these species can be grown on carrageenan gel media (Epifanio et al., 1981). If these bacteria had been able to degrade carrageenan, they would have liquified the gel medium on which they were growing. Pittman et al. (1976) reported breakdown of food grade carrageenan isolated from feces of guinea pigs, rats and monkeys. There was no indication of where the breakdown occurred. It is to be noted that there were no intestinal lesions associated with this breakdown, suggesting that the molecular weight attained was not as low as that of degraded carrageenan. Indeed, Pittman's data showed that the molecular weight was reduced to about 40 000 or 50 000 (compared to 10 - 20 000 for degraded carrageenan) irrespective of the species of animal it was fed to. Pittman's work also shows that degraded carrageenan is absorbed while the high molecular weight material is not. This is further proof that degradation in the gastrointestinal tract is limited. BIOLOGICAL DATA ABSORPTION Native carrageenan Rat Native carrageenan, untreated or heat sterilized in milk, is quantitatively excreted in the feces of the rat (Tomarelli et al., 1974). Chen et al. (1981) failed to find carrageenan present in the livers of rats fed 25 native carrageenan in the diet for one month. Similarly, subchronic rat feeding studies in which rats were fed diets containing 1 or 5% of carrageenan did not result in the storage of carrageenan in the liver (Coulston et al., 1975). Pittmann et al. (1976) fed rats diets containing 5% C. crispus carrageenan for 13 weeks and reported that carrageenan was not found in the liver. Grasso et al. (1973) did not detect the presence of carrageenan in the small and large intestine of rats fed 5% native carrageenan. Nicklin and Miller (1983) reported that orally administered carrageenan of high molecular weight could penetrate the mucosal barrier of adult animals via transport by macrophases in Peyer's patches. Carrageenan administration did not affect the number or distribution of these cells. However, when antigen was administered systematically to carrageenan fed rats the antigen specific antibody response was suppressed. This result suggest that carrageenan may interfere with antigen processing by macrophages and thus modify normal immune function. Analyzing liver samples from rats fed 25% native carrageenans (Chondrus crispus or iridaea) in the diet for one month only the second was found in the livers of two animals. Gamma metachromatic reaction sites were seen in the Kupffer cells of these two rats indicating the presence of carrageenan (Chen et al., 1981). Monkey Rhesus monkeys given 1% native carrageenan in drinking water for 7-11 weeks (with a subsequent 11-week recovery period) showed no evidence of storage of carrageenan (Abraham et al., 1972). In another study on rhesus monkeys, Mankes & Abraham (1975) found no tissue storage of carrageenan when the monkeys were given 1% native carrageenan in the drinking water for 10 weeks. Pittman et al. (1976) reported that monkeys receiving daily doses of native carrageenan (500 mg/kg) for 15 months excreted 12 µg of carrageenan per milliliter of urine. This value (12 µg) was reported to be at the limit of detectability of the method. Monkeys receiving 500 mg/kg, 200 mg/kg or 50 mg/kg of native carrageenan did not show evidence of storage of carrageenan in the liver or other organs after 7.5 years of oral administration (Abraham et al., 1983). Guinea pig Grasso et al. (1973) fed native carrageenan (Eucheuma spinosum) at 5% in the diet for 21-45 days which resulted in the accumulation of 36 to 400 µg carrageenan/g of cecal or colonic tissue. The carrageenan was contained intracellularly in macrophages. Engster and Abraham (1976) reported that food grade carrageenans administered as a 1% solution in drinking water for 2 weeks are not retained in the guinea pig cecum. Rabbit Udall et al. (1981) reported in an abstract that carrageenan could be detected in the liver, stomach and small intestine of new- born rabbits orally dosed with 40 mg undegraded carrageenan. Carrageenan was not detected in the cardiac or portal blood, 4 hours after the treatment. Degraded carrageenan Rat Rats given 5 g/kg of degraded carrageenan daily by stomach tube over a period of 12 weeks, showed a storage of the test compound in membrane-bound vacuoles both in hepatocytes and in mononuclear phagocytes (Kupffer cells). The stored material was metachromatic; acid phosphatase activity was detected at similar sites in hepatocytes but not in Kupffer cells (Abraham & Ringwood, 1977). Rats given 5% solution of the degraded carrageenan in the drinking water for 3 weeks, had carrageenan material in the spleen, liver, colon, kidney, cecum and ileum (Grasso et al., 1975). Monkey Rhesus monkeys were given solutions of 2% of degraded carrageenan in the drinking water for 7-11 weeks followed by a 24 weeks period of recovery, and 1-0.5% solutions for 14 weeks without recovery. Degraded carrageenan was taken up by, and selectively stored in lysosomes of the reticuloendothelial system in the liver (Abraham et al., 1972). Degraded carrageenan was administered in a 2% solution for 10 weeks in the drinking water to 6 rhesus monkeys. Two animals were allowed to recover for 24 weeks. Submucosal macrophages from the colon was observed to contain lysosomes with fibrillar material (carrageenan) even after a period of prolonged recovery (Mankes & Abraha, 1975). Guinea pig The administration of degraded carrageenan as 0.5 and 0.25% solutions in the drinking water for 4 and 12 weeks, or of 5% solution in drinking water for 5-9 days to guinea pig resulted in carrageenan storage in the intestine, spleen, liver and kidney (Grasso et al., 1973, 1975). Similar results were obtained by Pittman et al. (1976). Rabbit Three rabbits given 1.5 g/kg degraded carrageenan by gavage daily for 28 days had carrageenan in epithelial cells and macrophages of the caecum and proximal colon (Grasso et al., 1973). Pittman et al. (1976) concluded that the absorption of carrageenan depended on its molecular weight: the higher the molecular weight, the less material was absorbed. They estimated that molecules of molecular weight 10 000 to 85 000 represented an upper limit of the size of carrageenan molecules absorbed. This upper limit is likely to be influenced by the medium in which it is administered (i.e. drinking water or diet). Carrageenan is probably more "available" in drinking water than it is in the diet where it is likely to be complexed to dietary proteins. Engster & Abraham (1976) investigated the effect of carrageenan molecular weight and carrageenan type on cecal carrageenan accumulation. Food grade carrageenan (kappa and lambda) were not accumulated regardless of molecular weight, whereas accumulation of iota carrageenan occurred over a molecular weight range of 8 000 to 107 000. The apparent discrepancy between these results and the results of Pittman et al. (1976) are not explained. Systemic administration Rat Kappa, lambda and iota carrageenans were administered i.p. (125 g/kg) to Sprague-Dawley rats. Blood samples were taken after 1.5 hours, 1, 2, 4, 7 and 14 days. Each carrageenan (but especially kappa and lambda) caused thrombocytopenia and red-cell damage within 2 days, This was followed by rebound thrombocytosis and persistent anaemia, accompanied by a reticulocytosis. A two-fold increase in fibrogen was observed at 24 or 48 h (Davidson et al., 1981). Groups of Sprague-Dawley rats (7 male) were injected i.p. with 125 mg/kg carrageenan kappa, lambda and iota for 14 days. Kappa was clearly nephrotoxic (increase of serum urea, creatinina levels, N-acetyl-ß-delta-glucosaminidase and aspartate aminotransferase activity) (Thomson & Whiting, 1981). Mouse Native carrageenan was injected i.p. to mice 0.5-2.5 g/animal. The mice were killed 1-4 days after injection. Carrageenan inhibited the immune response to T-cell-dependent antigens, while the immune response to T-cell-independent antigens was not affected. Changes of the spleen weight and DNA synthesis in spleen cells were seen (Antoni et al., 1979). Five mg potassium carrageenan given to mice in 0.5 ml as a single i.p. injection was found to be hepatotoxic. Raised serum transaminase activity was correlated with necrosis of the liver (Fowler et al., 1977). TOXICOLOGICAL STUDIES Reproduction and teratology studies Rat In a three generation reproduction and teratology study groups of Osborne-Mendel rats (40 males and 40 females for each) were fed with a diet containing calcium carrageenan at levels of 0.5, 1.0, 2.5 or 5.0%. After weaning, all animals were fed carrageenan in their diets for 12 weeks before mating. Carrageenan ingestion caused dose-related and significant decrease in the weights of offspring at weaning, but no effects were detecteds in respect of fertility, average litter size, average number of liveborn animals, viability or survival of offspring. Diarrhoea was marked in animals fed the two highest dose levels (Collins et al., 1977a). Long-term multigeneration effects of the dietary intake of calcium carrageenan were measured in a three-generation reproduction and teratology study in Osborne-Mendel rats. Dietary levels of 0.5, 1.0, 2.5 or 5.0% were ingested throughout the study. Developmental effects were studied in the F2C and F3C litters. No dose-related effect on maternal weight gain was observed. The average numbers of corpora lutea, implantations and early or late deaths, and the average percentage resorptions per litter showed no dose-related differences. No specific external, skeletal or soft-tissue anomaly could be correlated with dosage (Collins et al., 1977b). Four groups each of 21-24 pregnant rats were fed 1%, 5% with sodium and calcium carrageenan from day 6 of gestation through day 16. In addition to the two dietary levels of each carrageenan, concurrent groups received the basal (control) diet and one group each received aspirin by stomach tube at the same levels currently used in positive controls. Terminal sacrifice for all groups was scheduled on day 20. The uterine contents were examined and the numbers of implants, resorptions, live and dead fetuses recorded, as was the average weight of the liver pups in each litter. All fetuses were examined grossly for evidence of external abnormalities. During the mid-trimester of gestation, the ingestion of diets containing as much as 5% of either the sodium or calcium salt of carrageenan has no detectable effect on maternal or fetal survival, on the rate of nidation, or on the degree of maturation of fetuses. Under the conditions of the experiment, neither material was a teratogen for rats (Bailey & Morgareidge, 1973). Sprague-Dawley rats were given a diet containing 1.8, 0.9 and 0.45% calcium carrageenan. Treatments were administered 14 days prior to mating, 1-14 days during breeding, throught gestation (22 days), lactation (21 days) and postweaning testing (69 days) i.e. from weaning at 21 days of age until the termination of the experiment at 90 days of age. Observations were made on reproduction and on the physical and behavioural development of the offspring. Effects observed in the carrageenan groups were inconsistent and not dose- related (Vorhees et al., 1979). Hamsters Four groups each of 21-26 pregnant hamsters were fed 1% and 5% with sodium and calcium carrageenan from day 6 through day 11. In addition to the two dietary levels of each carrageenan, concurrent groups received the basal diet and one group each received aspirin by stomach tube at the same levels currently used in positive controls. For all groups terminal sacrifice was scheduled on day 14. The uterine contents were examined and the numbers of implants, resorptions, live and dead fetuses recorded, as was the average weight of the live pups in each litter. All fetuses were examined grossly for evidence of external abnormalities. During the mid-trimester of gestation, the ingestion of diets containing as much as 5% of either sodium or calcium salt of carrageenan has no detectable effect on either maternal or fetal survival, and on the degree of maturation of fetuses. There was only a marginally significant reduction in the pregnancy rate of females fed 5% of the calcium salt in the diet. Under the conditions of the experiment, neither material was a teratogen for hamsters (Bailey & Morgareidge, 1973). Randomly selected syrian hamsters were intubated with sodium or calcium native carrageenan or degraded carrageenan in distilled water at dose levels of 10, 40, 100 or 200 mg/kg on days 6-10 of gestation. Animals of the control groups were intubated with distilled water on the same days. Day 0 was considered the day on which sperm were found in the vagina. At least 21 pregnant females were examined at each dose level of calcium and sodium carrageenan. Only eight pregnant females were tested at each dose level of degraded carrageenan as only a limited supply of this compound was available. The highest level of 200 mg/kg was chosen because the gelling capacity of the compounds precluded higher concentrations. The animals were killed on day 14. No dose-related teratogenic or foetotoxic effects occurred with any of the three compounds tested (Collins et al., 1979). Chick embryo Prior to incubation, 240 chick eggs were injected in the yolk sac 0.1 mg of a sterile suspension of the 0.1% lambda-carrageenan in 0.9% sodium chloride. For controls, 240 eggs were injected with 0.1 ml saline solution, and 240 eggs received no treatment. After mating, for assessing the potential embryotoxic effect of carrageenan, the following parameters were determined; mortality rate of embryos in which development based was arrested, retardations of development based upon body weight and length of 3rd toe and beak and incidence of gross malformations. Mortality of embryos in the groups injected with carrageenan was significantly higher than in the other two groups. Anomalies of treated groups were mainly localized in the cephalic end (exencephaly, abnormal beak, anophtalmy, etc.). All abnormal chicks of the group injected with carrageenan showed two or more anomalies. Growth of newborn chicks in the carrageenan-injected group was significantly diminished until the 4th day of age. So lambda carrageenan, in these experimental conditions, has teratogenic and lethal effects on chick embryo development (Rovasio & Monis, 1980). Furcellaran was tested for toxic and teratogenic effects to the developing chick embryos. It was administered in water via the air cell at pre-incubation (0 hours) and at 96 hours of incubation, and via the yolk at 0 hours at 96 hours. Administration of furcelleran at 0 hours by both routes resulted in a line whose slope was not significantly different from zero, while administration at 96 hours by both routes resulted in a line with a negative slope. No LD50 estimates could be made from the regression lines (Anonymous, 1976). Furcellaran was tested for toxic and teratogenic effects to the developing chicken embryo under four sets of conditions. It was administered in water as the solvent by two routes and at two stages of embryonic development; via the albumen at pre-incubation (0 hours) and at 96 hours of incubation, and via the yolk at 0 hours and at 96 hours using techniques that have been described previously. The route of albumen, instead of the usual air cell, was chosen because of the fact that the administered furcellaran solution formed globular coagulates as soon as it was injected into the air cell, and absorption through the embryonic membrane was not conceivable. Furcelleran was found to be quite embryotoxic when administered to the embryos under all conditions of the test. Probit analysis resulted in an LD50 of 1.611 mg/egg at 0 hours and that of 1.449 mg/egg at 96 hours via the albumen. Yolk treatment at 0 hours resulted in an LD50 of 1.089 mg/egg, while the same treatment at 96 hours resulted in a line whose slope was not significantly different from zero. From these results it cannot be concluded that furcelleran is teratogenic to the chicken embryo. However, it is a note-worthy finding that in both the albumen and yolk sac administration routes, with the higher dose levels (5.0 mg and 1.0 mg/egg) at 0 hours there were anomalies of the eye and maxilla which were not observed in the solvent-treated embryos. This may warrant an additional study of the effect of furcelleran on embryonic development (Hwang et al., 1974). Special studies on mutagenicity Sodium Carrageenan was tested for genetic activity in a series of in vitro microbial assays with and without metabolic activation on Salmonella typhimurium and Saccharomyces cerevisiae at the concentration 0.5, 1.0, 2.0%. The test compound, sodium carrageenan, did not demonstrate genetic activity (Brusik, 1975). In vivo cytogenic studies Furcellaran was administered to male rats with an average body weight of 300-350 gr. In the acute study (single dose) and in the subacute study (five doses) a dose of 5000 mg/kg was employed. Metaphase chromosome spreads were prepared from the bone, marrow cells of these animals and scored for chromosomal aberrations. Neither the variety nor the number of these aberrations differed significantly from the negative controls; hence, furcelleran can be considered non- mutagenic as measured by the cytogenetic test. Dominant lethal Furcellaran, edible, was administered to ten male rats (400 gr) at a dose level of 5 000 mg/kg according to acute (single dose) and subacute (five doses) protocols. Each treated male rat was mated with two virgin female rats each week for seven (subacute) or eight (acute) weeks. Two weeks after mating, these female rats were sacrificed and the fertility index, preimplantation loss and lethal effects on the embryos were determined and compared with these same parameters calculated from negative (saline-dosed) and positive (0.3 mg/kg TEM- dosed) control animals. The values calculated from these parameters from animals with compound FDA T-52, furcelleran, edible, did not significantly vary from those obtained from the negative controls, except for an increase in corpora lutea during week 2 of the acute. Since the increase in corpora lutea was not matched by an increase in the number of implants, it is also refelcted as a preimplantation loss. No unusual explanation for this increase in corpora lutea is apparent. TEM caused a significant preimplantation loss and embryo resorption during the first five weeks. Comparing these data with the previously obtained valus for dose levels of 715 mg/kg, 71.5 mg/kg and 7.15 mg/kg revealed no dose- response or time trend patterns, thus indicating that furcelleran does not include dominant lethal mutations as measured by this test. Effect on lipid metabolism One group of rats were fed 5% alphacel plus 15% undegraded carrageenan. The control group was treated with 5% alphacel. After 33 weeks the data indicated that dietary carrageenan exhibited cholesterol-lowering effect in rats, increase in feces weight and in the concentration and daily output of fecal cholesterol and total bile acids (Reddy et al., 1980). Short-term studies Degraded carrageenan Rat Groups of 10 male and 10 female Sprague-Dawley rats were given a 5% solution of degraded carrageenan in the drinking water for 3 months. Control rats received distilled water. The gross appearance and histology of the ceca was normal. On rare occasions, the cecum was slightly distended with soft, semi-fluid contents. The blood vessels in these ceca were more prominent than usual. Small groups of macrophages exhibited moderate acid phosphatase activity in cecal sections (Abraham et al., 1974). Four groups of rats were fed with basal diet (group I and II) or were fed diet containing 10% degraded carrageenan for two weeks and then basal diet for 28 weeks (group III and IV). Dimethylhydrazine (DMH) was administered subcutaneously to group II and IV at a dose of 10 mg/kg once a week for 15 weeks. The animals were observed for 30 weeks and then sacrificed. Colorectal squamous metaplasia of the mucosa was seen in all animals in group III (10% carrageenan) and IV (carrageenan + DMH). In the same groups erosions with active inflammatory reaction were observed in the colon. The incidence of tumours of the small intestine was 20% in group II and 50% in group IV. The incidence of intestinal tumors induced by DMH was higher in animals fed on diet containing degraded carrageenan than animals fed on basal diet (Kawaura et al., 1982). Degraded carrageenan was administered to rats as a 5% solution in the drinking water for 3 weeks. Other 2 groups (18 males and 18 females) received degraded carrageenan in drinking water at 0.5 and 0.25% for 12 weeks. At 5%, rats developed severe diarrhoea and gained less weight than the controls. Macroscopically no changes were evident in the caecum colon or rectum. Microscopically there was oedema in the distal part of the rectum but no clear evidence of microphage infiltration was present. Histochemically no carrageenan was demonstrable in the small or large intestine or rectum. The rats treated with 0.5, 0.25% degraded carrageenan appeared to be healthy throughout the experiment and gained weight. The feces were well formed but softer than normal (Grasso et al. 1975). Rats (10 males group) were given 5-1% degraded carrageenan in the drinking water for 56 days. The animals with 5% dose had diarrhoea with watery stools that was less evident with 1% level. No ulcerations were seen in both groups (Grasso et al., 1973). Guinea pigs 20 male guinea pigs receiving 5% degraded carrageenan in the drinking water for 5-9 days developed severe diarrhoea and began to lose weight after day 1. Occult blood was detected in the faeces from day 4 onwards and the condition of the animals deteriorated rapidly until they were killed between days 5 and 9. At autopsy, haemorrhagic areas were present in the wall of the caecum and proximal colon of all animals. Histopathological investigation revealed these to be large areas of gross submucosal oedema, haemorrhage and ulceration. The cellular infiltrate in the lamina propria consisted mainly of lymphocytes with few macrophages and polymorphonuclear cells. The addition of neomycin to the diet markedly reduced the population of polymorphonuclear cells in the ulcer but did not affect the apparent incidence of ulcers or the time of their appearance (Grasso et al., 1973). 10 female guinea pigs given 2% degraded carrageenan in the drinking water for 21-45 days developed multiple pinpoin caecal and colonic ulcerations after 3-5 weeks of treatment. Histologically, the ulcers consisted of extensive macrophage infiltration at the base, over which lay a thin layer of fibrin. Polymorphonuclear cells and lymphocytes were present in appreciable numbers. The epithelium around the ulcer was heavily infiltrated by macrophages, polymorphs and lymphocytes. In some animals, heavy polymorphonuclear infiltration occurred, leading to the formation of micro-abscesses close to the ulcerated areas. The addition of neomycin (0.1%) to the diet markedly reduced the population of polymorphonuclear cells in the ulcers but did not affect the apparent incidence of ulcers or the time of their appearance (Grasso et al., 1973). 20 male guinea pigs were given 1% degraded carrageenan in the drinking water. Groups of 2-3 animals were killed every 3-4 days up to 42 days. In another experiment with the same concentration, 28 male were treated for 3 weeks. Groups of 4 killed at week 1, 2, 3, 4, 7, 11 and 15. Caecal and colonic ulcers were seen in animals receiving 1% degraded carrageenan in the drinking water. The stages leading to ulceration were observed in the animals killed sequentially. Observation at week 2 showed an increase in the number of macrophages in the lamina propria. The macrophages often formed dense masses and obliterated the mucosal crypts (granulomas). They varied considerably in size: a few were visible to the naked eye as pale raised areas. This macrophage infiltration was present in five out of six animals examined. The collections of macrophages were strongly acid phosphatase-positive and ultrastructurally were shown to possess large vacuoles lined by single membranes. Macrophage necrosis was sometimes observed at week 3 and 4. Multiple ulcerations were found in seven of the 12 animals examined. They were pin-point in size when viewed macroscopically and were invariably found microscopically to be accompanied by marked macrophage infiltration. Loss of epithelium occurred only over areas of these pronounced macrophage accumulations. Carrageenan was demonstrable within the macrophages forming the base of the ulcer. Three out of four guinea pigs killed immediately after consuming a 1% solution of degraded carrageenan in the drinking water for 3 weeks were found to have caecal ulcerations. Histologically the lesions were similar to those observed in our earlier studies. No caecal or colonic ulceration was seen in animals killed 1 or 4 weeks after the cessation of treatment, but distinct granulomas with demonstrable carrageenan within the macrophages could be identified. In animals killed at a later date, the histology of the caecum and colon was indistinguishable from that in the controls and no carrageenan could be identified in the macrophages within the lamina propria (Grasso et al., 1973). Ingestion of the 2% of degraded carrageenan in drinking water by 8 female guinea pigs for 2 weeks resulted in ulcerative lesions in the caecum, and, to a lesser extent, in the colon, and in oedema of the mesentery and hypertrophy of the mesenteric lymph nodes. Sequential studies, conducted over a period of 7 to 14 days, of the changes leading to ulceration, revealed focal increases in the number of large foamy macrophages in the lamina propria between the glands. The epithelium overlying the macrophages became attenuated; more accumulation, death and disintegration of macrophages was associated with loss of glands and more severe degeneration of luminal epithelium. Ulceration occurred in these altered areas and was followed by infiltration of heterophils. Granulomas with a central core of large foamy macrophages were often observed in the submucosa beneath the ulcers. After 8 days of administration of the 2% solution, acid phosphatase activity was moderately increased, in the epitehlial cells as well as in the macrophages of the lamina propria. By 14 days, the time at which caecal ulcerations were predominant, a striking increase in acid phosphatase activity was observed in the epithelium and in the subepithelial macrophages, with formation of large dense particulates. A significant departure from normality in the form of an increase in the number of dense bodies (lysosomes) was noted in the epithelial cells (Abraham et al., 1974). 14 male guinea pigs received degraded carrageenan at 5% in the drinking water over periods from 20 to 45 days. All animals showed loss of weight (15-25%) which became apparent after the second week. At the end of the first week treated animals showed looseness of the stools. Tests for the occult blood in the faeces became positive in over half the animals by the 18th day and in all animals carrageenan-fed by the 30th day. Ulcerative lesions in the large intestine occurred in 12 of the 14 animals treated for 20 to 45 days. 4 animals were killed between the 20th and 25th days: 2 showed ulceration of the caecum and proximal colon. All guinea pigs killed on the 30th day (6) and between 35th and 45th days (4) showed ulcerative lesions in various parts of the large intestine. There was fatty change in the liver of 9 animals in experimental group (Watt & Marcus, 1971). 142 male guinea pigs treated with 5% (w/v) solution of degraded carrageenan for 30 days as the sole source of fluids. 21 or more days after the experiment was started, all animals had gross and microscopic evidence of disease (ulcerative lesions). None of the 10 untreated animals had any evidence of ulcerative lesions. Germfree guinea pigs given the same solutions for comparable periods of time did not develop caecal ulcerations (Onderdonk et al., 1981). Seven iota fractions with intrinsic viscosities (dl/g): 0.113, 0.285, 0.685, 1.62, 4.19, 5.34 and 7.51 (molecular weights from 5 000 to 145 000); three kappa fractions: 0.177, 1.45 and 11.95 (molecular weights 8 500, 51 500 and 314 000) and three lambda fractions: 0.503, 2.243 and 10 250 (molecular weights 20 800, 74 800 and 275 000) were given to female guinea pigs as a 1% solution in the drinking water for 2 weeks. Six of these iota fractions (0.113 dl/g was not used) were also fed to female guinea pigs in the diet at 2% level for 10 weeks. When given in the drinking water, all iota fractions except those with intrinsic viscosities (dl/g) of 0.113 and 7.51 were absorbed and retained in acecal lamina propria and submucosal macrophages as indicated by toluidine blue staining, by the presence of fibrillar material in membrane-bound vacuoles, and by increased lysosomal acid phosphatase activity. Histopathological changes in the caecum of guinea pigs given iota fractions of intrinsic viscosities (dl/g) 0.285, 0.685, 1.62, 4.19 and 5.34 in the drinking water were epithelial thinning, slight erosion, cellular infiltration and crypt abscesses. Ulceration of the caecal mucosa was present in guinea pigs given the two iota fractions of 0.685 and 1.62 dl/g in the drinking water. The lowest (0.113 dl/g) and highest (7.51 dl/g) iota fractions, administered in the drinking water, were neither absorbed nor stored nor caused any histopathological effects. Iota fractions given to guinea pigs in the diet produced no inflammatory response, erosion or ulceration of the caecum. Caecal damage was not noted in groups of animals given the kappa and lambda carrageenan fractions in drinking water (Engster & Abraham, 1976). Five male guinea pigs were given 5% degraded carrageenan in the drinking water for 2 weeks. The carrageenan group consistently lost weight throughout the treatment period in comparison to the control. Animals carrageenan treated ate considerably less than the controls (-45%). Also fluid consumption was depressed in the carrageenan groups (-44%). One animal died on the 10th day. The group receiving carrageenan showed a high incidence of fecal occult blood in the caecum upon autopsy. One animal had a slight heamorrhage along the caecum vessels. A second animal had congested vessels on the mucosal surface. The caecum of the other animals appeared normal (Boxenbaum & Dairman, 1977). In another experiment 2% degraded carrageenan was dissolved in milk and given to 3 guinea pigs over a three months period. An equal number of control animals received milk alone. Ulcers were not observed in the caeca of treated guinea pigs. Histological examination revealed both the mucosa and submucosa to be normal in disposition. Most macrophages in the lamina propria showed no metachromasia. In contrast to the macrophages in the lamina propria, those in the submucosa were strongly metachromatic, as were the fibroblasts and endothelial cells. Acid phosphatase activity was not increased, and distribution of lysosomes was similar to control animals. All the caeca of guinea pigs receiving milk alone were normal and similar to control animals (Abraham et al., 1974) Monkey 6 monkeys (Macaca mulatta) male and female, were given 2% degraded carrageenan in drinking water for 10 weeks. Equal number of control animals were used. The monkey caecum was normal in all respects in treated animals. Both groups had normal epithelium, glands, lamina propria and muscularis mucosa. In the treated animals there were numerous macrophages in the submucosal region that contained fibrillar (carrageenan) material. Cells containing carrageenan-like material were absent in other areas of the caecum (Abraham et al., 1974). 5 males and 5 females received various concentrations of degraded carrageenan in the drinking water up to week 14. 6 animals drank a 2% solution, 2 a 1% solution and the remaining 2 a 0.5% solution. The corresponding average daily intakes of degraded carrageenan were calculated to be 2.9, 1.4 and 0.7 g/kg respectively. 2 monkeys from the 2% were sacrificed after 7 and 11 weeks of exposure. The remaining 4 animals were kept on their dosage regimen for 14 week and then allowed to recover on tap-water for a period of 20-24 weeks, when they were killed. The 4 animals given the other dose levels were killed at the end of the 14 week treatment period. 2 males and 2 females monkeys were used as controls. 5 out of the 6 monkeys given 2% degraded carrageenan did not gain weight. Almost immediately after the onset, the consistency of the stools became loose and watery. After 2-3 weeks occult blood was found in stool samples and melaena appeared sometimes associated with discharge of frank blood and mucus. Monkeys given lower levels of degraded carrageenan (1 or 0.5%) gained weight or maintained their initial body weight. Faeces were for the most part firm or soft, rarely loose or watery. Occult blood in the faeces appeared 2-3 weeks after the beginning of treatment. In one animal killed at 7 weeks (2% degraded carrageenan) the entire intestinal tract was macroscopically normal and the microscopic abnormalities were limited to the colon. In a monkey killed at 11 weeks more pronounced changes were seen in the caecum and colon and their regional lymph nodes. Microscopically, slight oedema, increased number of macrophages, two submucosal abscesses were seen. The colon had multiple fresh mucosal haemorrhages throughout its entire length, ulcerations and crypt abscesses. The two monkeys that received 1% degraded carrageenan for 14 weeks had similar lesions in the lower intestinal tract. The abnormal findings in the 2 animals given 0.5% degraded carrageenan for 14 weeks were less conspicous. Only the female had several mucosal haemorrhages. In the four monkeys that had received 2% degraded carrageenan for 14 weeks followed by a 24 week recovery period, the tests for fecal occult blood were positive for 10 weeks after the withdrawal of carrageenan. At the autopsy the intestinal tract was grossly and microscopically normal in both males. In one female several large deep crypt abscesses with degenerative changes of the epithelium were found in the colon. The colon of the 2nd female had two ulcers (Benitz et al., 1973). 2 female squirrel monkeys were given 1.5 g/kg body weight of degraded carrageenan by gavage daily for 28 days. Soft faeces were the principal effect produced. The treated animals did not develop ulcers (Grasso et al., 1973). Rabbit 3 female rabbits received 1.5 g/kg bw. of degraded carrageenan by gavage daily for 28 days. Faecal softening was the principal effect. Granuloma formation was seen in the caecum and proximal colon of the 3 rabbits, but ulceration was visible macroscopically in only one (Grasso et al., 1973). Ferret 3 females were given 1.5 g/kg by gavage of degraded carrageenan for 28 days. Soft stools were observed (Grasso et al., 1973). Hamster 8 female hamsters were given 5% degraded carrageenan in the diet for 6 months. The animals developed a frank diarrhoea with watery stools. No ulcers were present in the gastro-intestinal tract (Grasso et al., 1973). Native carrageenan Rat A single dose of 0.5 to 50 mg native carrageenan was given to Lewis rats by gavage. Low doses of carrageenan resulted in significant suppression of spleen and mesenteric lymph node responses to the phyto-hemagglutinin (PHA) while high doses showed no effect. In a second series of experiment, 2 litters of DA rats were weaned on distilled water containing 0, 0.1, 1 mg/ml carrageenan for 8 weeks (daily intake of carrageenan was 2.3 and 23.1 mg respectively). The dose of 0.1 mg/ml markedly suppressed spleen cell responses to PHA while 1 mg/ml gave responses equivalent to the water controls (Bash & Vago, 1980). RE 7064 Iridaea carrageenan (25%) was incorporated into three different basal diets: WayneR Lab Blox, a commercial rodent diet prepared from chemically undefined sources; TD 76110, a complete high protein synthetic rodent diet and TD 76112, identical to TD 76110 except for the deletion of vitamin E. Rats fed RE 7064 in WayneR diet for 4 weeks lost weight and their growth was retarded. Soft stools, decreased relative liver weight and gross hepatic atrophy were also observed. In contrast to these effects, rats fed RE 7064 in TD 76110 showed no adverse effects. Reduction of dietary protein by simple dilution yields 18% protein in WayneR diet (TD diets are not affected by dilution, their protein value remains at 25%). It is thus suggested that protein binding by Iridaea carrageenans reduces the dietary availability of protein below a minimal requirement and produces hepatic atrophy (nutritional atrophy). Rats fed vitamin E deficient TD 76112 for 3 weeks, with or without 25% RE 7064, did not develop vitamin E deficiency. Despite this obvious shortcoming it appears that high protein diet still prevents hepatic atrophy, as only 1/6 rats given RE 7064 in TD 70112 developed liver atrophy. Neomycin sulfate was incorporated at the level of 50 mg/kg of either WayneR diet and 25% RE 7064 and fed to rats for 4 weeks. This treatment failed to either protect or alter the atrophic response of rats fed RE 7064. Surprisingly, rats fed neomycin alone had in their livers numerous inflammatory foci, councilman bodies and autophagic vacuoles. These observations have not been previously reported. As neomycin sulfate inhibits protein absorption, the similarity of hepatic changes in rats fed RE 7064 and those fed neomycin sulfate support the concept of protein depletion being responsible for initiation of hepatic atrophy. Autophagic vacuoles were present after 2 weeks of recovery but were rarely seen after 4 weeks. Further, no evidence of fibrosis or repair was seen in liver sections. In keeping with earlier studies, carrageenan was stored in Kupffer cells even after 4 weeks of recovery (Mankes R.F., 1977). Rats received for 50 days native carrageenan in the diet of 0, 15 and 25% level (10 females and 10 males each group; 25 males and 25 females the control group). It was noted on the 4th day that all the animals receiving the test diet had begun to develop diarrhoea. The symptoms appeared more marked at the 25% level than at the 15% level. Males and females at the 25% level excreted bloody stools. All of the animals receiving native carrageenan on the 8th day appeared to be losing hair from the dorsal mid-line surfaces on the back. The symptoms were more severe at the 25% level and in the females. On the 31st day 5 males and 5 females for each group were killed. The carrageenan treated animals appeared smaller than the control. On the 50th day the remaining animals were sacrificed and necropsied. No gross pathological abnormalities were noted. Many of the livers examined had a mottled appearance, but this phenomenon occurred also in the control rats. The rate of feed consumption for the test animals was generally less than the controls (Anonymous, 1975). Nutritional studies were conducted on rats fed diets containing carrageenan that had been mixed into skim milk at a concentration equal to that of the protein. When fed in a simulated milk powder diet, the processed carrageenan at a dietary level of 4% had no influence (compared to glucose or cellulose) on growth rate, diet energy efficiency, absorption of protein, fat, calcium, blood coagulability, utilization of protein for growth, or utilization of iron. Gross and microscopic examination of the caecum and colon, after 6 months feeding, revealed no abnormalities (Tomarelli et al., 1974). The effect of dietary undegraded carrageenan (Viscarin 402) on colon carcinogenesis was studied in female inbred F344 rats. Weanling rats were fed semipurified diets containing 0 or 15% undegraded carrageenan. At 7 weeks of age, all animals except controls were given azoxy-methane (AOM) s.c. at a dose rate of 8 mg/kg body weight per week for 10 weeks or methylnitrourea (MNU) intrarectally at a dose level of 2 mg/rat twice a week for 3 weeks. The AOM groups were autopsied 40 weeks and MNU groups 30 weeks after the first injection. No tumors were induced in the colon or in other organs of untreated rats fed the control diet. One untreated rat fed the carrageenan diet showed a colon adenoma. The animals fed the carrageenan diet and treated with AOM or MNU had a higher incidence of colorectal tumors (number of rats with colorectal tumors and number of tumors per tumor-bearing rat) than did those fed the control diet and treated similarly. The undegraded carrageenan (Viscarin 402) in the diet had an enhancing effect in colorectal carcinogenesis in rats evoked by AOM or MNU (Watanabe et al., 1978). Iridaea carrageenan was given orally to groups of 15 male and 15 female rats at dietary levels of 1% or 5% for 90 to 92 days. A group of 13 males and 17 females was given 5% alpha cellulose and served as control. No remarkable compound related changes in behaviour, body weight, food consumption, hematology, clinical chemistry, urinanalysis, fecal analysis, gross pathology, histochemistry, or electron microscopy were elicited at any dose level. However, councilman bodies, increased frequency of monocytic accumulations and pigmented Kupffer cells were noted in liver sections from rats fed 5% Iridaea carrageenan. In addition, high dose rats displayed significant decreases in lung weight, spleen weights, and brain-heart weight ratio (only in females) after 90 days. Mid-dose rats of both sexes had only an increased frequency of monocytic accumulations and councilman bodies in liver sections (Abraham et al., 1979). Guinea pig Female guinea pigs received 5% native carrageenan in the diet for 21-45 days. The animals developed multiple pin-point caecal and colonic ulcerations after 3-5 weeks. Histologically, the ulcers consisted of extensive macrophage infiltration at the base, over which lay a thin layer of fibrin. Polymorphonuclear cells and lymphocytes were present in appreciable numbers. The epithelium around the ulcer was heavily infiltrated by macrophages, polymorphs, and lymphocytes. In some animals, heavy polymorphonuclear infiltration occurred, leading to the formation of micro-abscesses close to the ulcerated areas. The addition of neomycin to the diet markedly reduced the population of polymorphonuclear cells in the ulcers but did not affect the apparent incidence of ulcers or the time of their appearance (Grasso et al., 1973). Mouse 25% RE 7064 (Iridaea) given in the diet to mice for 4 weeks resulted in significant decreases in body weight, growth and relative liver weight. Unlike the rat, however, no gross hepatic atrophy was observed. Histologic examination of the livers from these mice revealed eosinophilic (autophagic) vacuoles, focal inflammation and occasional necrosis of hepatocytes. Carrageenans were found both within vacuoles of Kupffer cells and hepatocytes, and unlike the rat, mitochondrial aberrations were observed in mouse hepatocytes (Mankes R.F., 1977). Monkey 3 males and 3 females Rhesus monkeys received native carrageenan in the drinking water as a 1% solution corresponding to an average daily intake of 1.3 g/kg. Two animals were sacrificed after 7 and 11 weeks respectively, the remaining four being put back on plain tap-water and allowed to recover for 11 weeks. These animals were then used for a dose-ranging experiment, using excalating daily doses of carrageenan ranging from 50 to 1250 mg/kg daily for up to 12 weeks. The highest dose was given for 8 weeks. After this second period of exposure, all four monkeys were killed. All animals gained weight and remained in good condition. Occult blood occurred sporadically in the faeces as was the case in controls. Only minor changes, none attributable to carrageenan administration, were found in the intestinal tract at autopsy and on microscopic examination. Similar findings were recorded in animals given 1% native for 11 weeks and subsequently after a recovery period of up to 11 weeks on tap-water, given escalating daily doses of 50-1250 mg native/kg for up to 12 weeks (Benitz et al., 1973). Male and female infant baboons were reared from birth to 112 days of age on infant formulas containing concentrations of 300 and 1500 mg/l of carrageenan (equivalent to 86 and 432 mg/kg/day). For the first 14 days, the animals were fed 5 times per day; four times for the next 14 days; 3 times for the next 56 days and 2 times for the 28 days until 112 days of age. Carrageenan content of the formula did not affect weight, characteristics of urine and faeces, findings on physical examination, hematological variables, blood chemical analyses, organ system weights, or the macroscopic and microscopic appearance of the gastrointestinal tract (McGil et al., 1977). Rat Two strains of rats (Osborne/Mandel and Sprague-DawleyL) were given two basal diets (FDA and AMC) as well as 5% carrageenan for 9 months. 18 males and 18 females were employed in each group. The control animals were treated with 5% alphacel in the diet. No significant macroscopic or microscopic changes were observed in the liver related to the administration of carrageenan. Livers were normal in both control (alphacel) and treated rats on gross and microscopic examination obtained from both strains of rats. No evidence of storage of carrageenan-like material (metachromatic) was observed in the parenchymal or Kupffer cells of the rats in all the groups examined by light microscopy; no fibrillar material (carrageenan-like material) was observed by electron microscopy in the livers in any of the groups; changes were observed in the appearance of the stools (soft and semi-fluid) at the 5% level with both strains of rats; occult blood in the faeces was sporadic in all groups in time of appearance and quantity (Coulston et al., 1976). Different groups of Sprague-Dawley rats received 5-1% of the three types of carrageenan (kappa from Chondrus crispus, lambda from Gigartina acicularis, iota from Eucheuma spinosum) in the diet for 9 months (15 males and 15 females). The control animals were given 5% alphacel in the diet. 5 male and 5 female rats from each group were killed at 3 months. The complete gross examination did not result in any grossly detectable abnormalities. No morphollogical changes were seen. Rats receiving both 5% and 1% carrageenan in the diet over a 40 week period grew well. Occult fecal blood was detected in 75% of the rats given 5% alphacel and in 25-50% of the rats fed the two levels of carrageenans. Stools in treated rats were slightly soft. No metachromatic material was noted in either hepatic or Kupffer cells in rat livers. No fibrillar material (carrageenan) was present in Kupffer cells or hepatocytes (Coulston et al., 1975). Degraded carrageenan Long-term studies Rat 30 male and 30 female rats were given 10, 5, 1 and 0% of degraded carrageenan (average m.w. 20-40 000) in the diet up to 24 months. Grossly visible blood on the surface of the stools and soft to semi-fluid stools were present in 10% and 5% groups. Colorectal squamous metaplasia and tumors were observed in 10% and 5% dose levels. Metaplasia was first observed in both groups after 6 months and final incidence was 98.3% and 88.3% respectively. The tumors were squamous cell carcinomas, adenocarcinomas and adenomas. Tumors were first observed in both groups after 12 months and final incidence was 31.7% and 20% respectively. No effect was observed with 1% degraded carrageenan treatment (Wakabayashi et al., 1979). 20 male and 20 female Sprague-Dawley rats were given a 5% aqueous solution of degraded carrageenan as drinking water for 15 months. The control groups received distilled water. Colorectal squamous metaplasia was first observed after 4 months and the final incidence was 100%. Tumors (squamous cell carcinomas, adenocarcinomas, adenomas and amyosarcoma) were first observed after 10 months and the final incidence was 17.5% (Wakabayashi et al., 1978). Groups of 10 male and 10 female rats were given either a 5% solution of degraded carrageenan as their sole source of drinking water or a dose of 5 g of degraded carrageenan per kg in aqueous solution by stomach tube (once daily, 6 days per week) for 15 months. Groups of 5 rats of each sex, given distilled water, either as drinking fluid or by stomach tube, served as controls. Rats were killed at intervals ranging from 1 to 15 months. At 15 months, degraded carrageenan was withheld from the 2 remaining rats - one female from the group that had received degraded carrageenan in drinking water, and one male from the group that received it by stomach tube. These rats were killed at 17 and 16.5 months, respectively. In the second experiment, groups of 20 female rats were given by stomach tube, daily doses of 0.5 and 5 g/kg for 6 months. A control group of 20 female rats was given daily doses of distilled water. Four rats were killed from each group at 4, 17 and 26 weeks. Additional rats were killed from the 5 g/kg group at 9, 14 and 19 weeks. In rats given 5 /kg by gavage, or 5% solution as drinking water (6 to 10 g/kg/day) the stools were soft to semi-fluid. Occult blood was first detected in those faeces within 3 to 7 days. After 2 to 3 weeks grossly visible blood was occasionally seen on the surface of the stools. Administration of degraded carrageenan to rats in daily doses of 5 to 10 g/kg resulted in squamous metaplasia of the rectal mucosa and accompanied by accumulation of metachromatic material (presumably carrageenan) in macrophage lysosomes. Such changes were not observed in rats given 0.5 g/kg/day for 6 months (Fabian et al., 1973). Eight-week-old male Fischer 344 rats were maintained on a diet containing 10% degraded carrageenan. Thirty-nine animals received this ratio for two months (group 1), 42 animals for six months (group 2) and 42 animals for nine months (group 3), respectively. Forty-six additional animals, referred to as controls, received the same diet without carrageenan. No mortality had occurred by 18 months following the start of the carrageenan feeding, when all animals were sacrificed. A 100% incidence of colorectal squamous metaplasia was found in all treated groups. Tumors were also reported in 5/39 animals in group 1 (3 squamous-cell carcinomas, 1 adenoma, 1 anaplastic carcinoma), 8/42 in group 2 (6 squamous-cell carcinomas, 1 adenocarcinoma, 1 adenoma) and 17/42 in group 3 (14 squamous-cell carcinomas, 4 adenicarcinomas). Colorectal changes were detected in none of the control rats (Oohashi et al., 1981). Groups of rats of 15 males and 15 females each were given 5, 1 and 0 g of degraded carrageenan/kg body weight by stomach tube for 15 months. The control group was given distilled water. In group 1 (5 g/kg) colorectal squamous metaplasia was first observed after 15 months. Metaplasia alone was observed after 14 months in group 2 (1 g/kg). Final incidence of metaplasia in groups 1 and 2 was 100% and 36.7% respectively. Colorectal tumors (adenocarcinomas and adenomas) were first observed in group 1 after 15 months and the final incidence was 27.6% (Wakabayashi et al. 1978). Guinea pig 0.02 and 0.2% degraded iota carrageenan was given in drinking water to 8 females for 12 and 10 months respectively. The gross appearance and the histological organization of the caecum and colon were normal. The number of macrophages within the lamina propria of the caecum was similar to that in control animals, but on staining with toluidine blue, a few of the macrophages from the 0.2% degraded carrageenan animals contained metachromatic material (Abraham et al., 1974). Native carrageenan Rat Groups of 30 male and 30 female of MRC rats received native carrageenan at dose levels of 5%, 2.5% and 0.5% in the diet for the lifespan. A group of 100 males and 100 females served as control. Average daily carrageenan intake was 4.022, 1.998, 0.360 g/kg respectively. Animals occasionally develop a solf stool consistency, particularly at the beginning. The histopathololgical alterations in rats could not be attributed to the prolonged action of carrageenan (Rustia et al., 1980). Rats (Sprague-Dawley) were given two types of carrageenan (RE 7063, an extract of Hypnea and RE 7064, an extract of Iridaea) in the diet at levels of 1% and 5% for one year. Significant weight loss (p = 0.05) was observed in male and female rats fed the two types of carrageenan at both levels as compared to the alphacel control group. Livers were normal at the 1% diet level on gross and microscopic examinations obtained from rats receiving the two carrageenans. Gross and microscopic examinations of livers obtained from 5% RE 7063 animals were normal in all respects except for 2/12 livers, that had nodules. Gross observations on the liver in the group of rats receiving 5 RE 7064 indicated a) ten rats (10/13) had decreased in size, rough surface and vacularization of the livers and probably related to the administration of RE 7064 at the 5% level in the diet; b) microscopically these livers were normal in the 5% carrageenan (RE 7064) group with the exception of 1 out of 10 where focal necrosis was noted. No evidence of storage of carrageenan-like material (metachromatic) was observed in the liver cell of rats in all the groups. No fibrillar material (carrageenan) was observed by electron microscopy in the livers of any of the groups. No changes were observed in the stools at 1% level with either carrageenan. Female rats (RE 7064 5%) showed loose stools (12/100). Male rats given either carrageenan at the 5% level also showed loose stools. Hematest results in all groups were sporadic in appearance and therefore not significant. Except for gross changes in the livers in one group (RE 7064 at 5%) no chemical-related effects were observed in rats in this experiment (Coulston et al., 1975). Monkey 40 Rhesus monkeys (19 male and 21 female) were given 0, 50, 200, 500 mg/kg bw. native carrageenan by gavage daily for six days a week for the first 5 years. Thereafter for the remaining 2.5 years, carrageenan was incorporated into diet and given to monkeys. Loose stools, chronic intestinal disorders, poor appetite and emaciation were seen in an apparently random distribution. Stool consistency was decreased in a dose related trend over 7.5 years while positive fecal occult blood findings were increased in a similar fashion. No statistical differences in mean survival times were detected in any group as compared to controls. No gross or microscopic changes were detected in tissues examined. Sporadic body weight changes from controls were noted in a random fashion. Only females had significant body weight depression from years 5 to 7.5, which did not appear to be dose-related. No consistent statistically significant changes occurred in hematology, clinical chemistry values, absolute organ weights, or organ to body weight ratios after 7.5 years of feeding carrageenan. Cytochemical and ultrastructural observations revealed no storage of carrageenan-like material in livers obtained at biopsy or in other organs obtained at necropsy from monkeys given carrageenan. No other gross or microscopic changes in tissues occurred in a dose-response relationship (Abraham et al., 1983). Hamster 30 male and 30 female Syrian golden hamsters received native carrageenan at dose levels of either 5%, 2.5% or 0.5% in the diet daily for the lifespan. The animals did not develop neoplasm in response to treatment at any dose levels. The histological alterations in hamsters could not be attributed to the prolonged action of carrageenan (Rustia et al., 1980). OBSERVATIONS IN MAN Six patients suffering from malignant disease of the colon were given 5 g degraded carrageenan daily for 10 days before a colectomy was performed. Samples of normal sections of the colon obtained at surgery were examined for any signs of ulceration and analyzed histochemically and chemically for the presence of degraded carrageenan in the tissue. There were no signs of any ulceration in these samples of gut, nor was degraded carrageenan detected by either the histochemical or the analytical method (Grasso et al., 1973). Comments Carrageenan is a high molecular weight sulfated galactan derived from a number of species of red seaweeds of the class Rhodophyceae. The carrageenan used in food has a high molecular weight (800 000 / 100 000) and has useful thickening and gelling properties at concentrations as low as 0.01%. Degraded carrageenan has a very low molecular weight (20 000 / 30 000) and has no gelling properties whatsoever, even at very high concentrations of 10% or more. Most of the degradation takes place in the stomach and that limited degradation has no effect on the gut wall. In vitro experiments with kappa and lambda mixture showed that in three hours the breakdown of glycosidic linkages was less than 0.1%. Carrageenan is resistant to attack by bacteria and degradation by human intestinal bacteria is very rare. Even though there are indications that the microbial flora of the rat gut at any rate, will not break down carrageenan, it has been reported breakdown of food grade carrageenan (40 000/50 000 MW) isolated from faeces of guinea pigs, rats and monkeys. There were no intestinal lesions associated with this breakdown; in fact, the molecular weight attained was not as low as that of degraded carrageenan. In in vitro mutagenesis assays native carrageenan was not mutagenic to S. typhimurium strains TA-1555, TA-1537 or TA-1538 or the yeast strain S. cerevisiae D4, with or without metabolic activation. In teratology studies with dietary concentrations up to 5% native carrageenan given to rats and hamster resulted in no adverse effects. In utero exposure of rat to undergraded carrageenan caused no effects on physical or behaviour development of offspring of parental animals fed 1.8% prior to mating during gestation and lactation and after weaning. Injection of 0.1% native carrageenan into the yolk sac of chicken eggs has resulted in increased lethality, a decrease in hatching weight and a slight increase in malformations. In a three-generation rat reproduction study a decrease in birth weight and body weights at weaning were seen in the offspring of dams fed 1.0, 2.5 and 5.0. No effects were seen on reproductive parameters at any dose level. Native carrageenan administered in the food to rats at concentrations of more than 5% showed no adverse effects in studies ranged from 30 days to 12 months. The administration of 5% carrageenan in the diet for 21-45 days to guinea pigs caused caecal and colonic ulcerations. No adverse effects were seen when native carrageenan was administered to infant baboons (432 mg/kg bw) and to Rhesus monkeys (1300 mg/kg bw) for 112 days and 12 weeks respectively. Rats and hamsters have been fed 5% carrageenan for their lifetimes. Survival was not affected in either species. No statistically significant pathological effects were seen in either species at any of the dietary level used in the study. Rhesus monkeys have been fed 500 mg/kg/day for 7.5 years. The only effects seen were soft stools or diarrhea and occasional fecal occult blood which was also seen in untreated controls. No pathologic effects attributable to the intake of carrageenan were seen in the monkeys. Degraded carrageenan administered in dose above 1%, whether in a water or food vehicle, causes ulceration and metaplasia of colorectal region of the intestinal tract in rats. The ulcerative effects reported for the low molecular weight degraded carrageenan appear dependent upon the animal species and the method of oral administration. In fact, guinea pigs and rats are the most susceptible species to ulcerative changes in the large bowel. There were no signs of an ulceration in samples of gut, nor was degraded carrageenan detected by either the histochemical or the analytical method when six patients were given 5 g degraded carrageenan daily for 10 days. EVALUATION Estimate of acceptable daily intake for man Not specified. REFERENCES ABRAHAM, R., GOLBERG, L., & COULSTON, F. (1972) Uptake and storage of degraded carrageenan in lysosomes of reticulo-endothelial cells of the Rhesus monkey Macaca mulatta. Exp. Mol. Path., 17: 77. ABRAHAM, R., FABIAN, R.J., GOLBERG, M.B., & COULSTON, F. (1974) Role of lysosomes in carrageenan-induced cecal ulceration. Gastroenterology, 67; 1169. ABRAHAM, R. & RINGWOOD, N. (1977) Effects of lyposomotropic agents on the hepatic uptake and storage of degraded carrageenan. Disparity in response of hepatocytes and Kupffer cells. Exp. Mol. Path., 26: 13. ABRAHAM, R., BENITZ, K.F., ROSENBLUM, I., MANKES, R.F., & RINGWOOD, N. (1983) Studies on Rhesus monkeys (Macaca mulatta) receiving native carrageenan (Chondrus crispus) orally for 7.5 years. Unpublished report from Institute of Experimental Pathology and Toxicology. Albany Medical College, submitted to the WHO. ANONYMOUS (1975) Toxicology laboratory report T-5162. Submitted from Stauffer Chemical Co., Western Research Center, to the WHO. ANONYMOUS (1976) Unpublished report, submitted to the WHO. ANTONI, P., PEUER, L., HRABAK, A., & STAUB, M. (1979) The effect of carrageenan and glutaurine on DNA synthesis of spleen cells in CFLB mice. Biochem. Med., 22: 238. BAILEY, D.E. & MORGAREIDGE, K. (1973) Teratologic evaluation of carrageenan salts in rats and hamsters. Unpublished report from Food and Drug Research Laboratories, Inc. (FDRL), submitted to the WHO by Hercules, Marine Colloids, Stauffer Chemical Co. BASH, J.A. & VAGO, J.R. (1980) Carrageenan-induced suppression of T lymphocytes proliferation in the rat: in vivo suppression induced by oral administration. J. Reticulo-end. Soc., 28(3): 213. BENITZ, K.F., GOLBERG, L., & COULSTON, F. (1973) Intestinal effects of carrageenans in the Rhesus monkey. Fd. Cosm. Toxicol., 11: 565. BOXENBAUM, H.G. & DAIRMAN, W. (1977) Evaluation of an animal-model for screening of compounds potentially useful in human ulcerative colitis: Effect of salicylazosulfapyridine and prednisolone on carrageenan-induced ulceration of large intestine of guinea pig. Drug Develop. Ind. Pharmacy, 3 (2): 121. BRUSIK, D. (1975) Mutagenic evaluation of compounds. Unpublished report from Litton Bionetics, Inc., submitted to the WHO by United States Food and Drug Administration. CHEN, J., APPLEBY, D.W., WEBER, P., & ABRAHAM, R. (1981) Detection of a carrageenan in rat liver homogenates after feeding in diet. Toxicologist, 1: 133. COLLINS, T.F.X., BLACK, T.N., & PREW, J.H. (1977a) Long-term effects of calcium carrageenan in rats. 1. Effects on reproduction. Fd. Cosm. Toxicol., 15: 533. COLLINS, T.F.X., et al. (1977b) Long-term effects of calcium carrageenan in rats. 2. Effects on fetal development. Fd. Cosm. Toxicol., 15(6): 539. COLLINS, T.F.X., BLACK, T.N., & PREW, J.H. (1979) Effects of calcium and sodium carrageenans and 1-carrageenan on hamster foetal development. Fd. Cosm. Toxicol., 17: 443. COULSTON, F., GOLBERG, M.B., ABRAHAM, R., BENITZ, K.F., & FORD, W. (1975) Safety evaluations of carrageenans (Hercules Inc.) Nine months study. Unpublished report from Institute of Experimental Pathology and Toxicology, Albany Medical College, submitted to the WHO. COULSTON, F., ABRAHAM, R., BENITZ, K.F., & FORD, W. (1975) Carrageenans (Marine Colloids) safety evaluation. One year study. Unpublished report from Institute of Experimental Pathology and Toxicology. Albany Medical College, submitted to the WHO. COULSTON, F., ABRAHAM, L., BENITZ, K.F., & FORD, W. (1976) Response of the livers of male and female rats (Osborne/Mendel and Sprague-Dawley) to alphacel and a carrageenan (HMR) for nine months using two different basal diets. Unpublished report from Institute of Experimental Pathology and Toxicology. Albany Medical College, submitted to the WHO. DAVIDSON, R.J.L., SIMPSON, J.G., WHITING, P.H., MILTON, J.I., & THOMSON, A.W. (1981) Haematological changes following systemic injection of purified carrageenans (kappa, lambda and iota). Br. J. Exp. Path., 62: 529. EKSTROM, L.G. & KUIVINEN, I. (1983) Molecular weight distribution and hydrolysis behaviour of carrageenans. Carbohydrate Res., 116: 89. ENGSTER, M. & ABRAHAM, R. (1976) Cecal response to different molecular weights and types of carrageenan in guinea pig. Toxicol. Applied Pharmacol., 38: 265. EPIFANIO, E.C., VEROY, R.L., UYENCO, F., CAJIPE, G.J.B., & LASERNA, E.C. (1981) Carrageenan from Eucheuma spiratum in bacteriological media. Applied Environ. Microbiol., 41: 155. FABIAN, F.J., ABRAHAM, R., COULSTON, F., & GOLBERG, L. (1973) Carrageenan-induced squamous metaplasia of the rectal mucosa in the rat. Gastroenterology, 65: 265. FOWLER, E.L., THOMSON, A.W., & HORNE, C.H.W. (1977) Alleviation of carrageenan-induced hapatoxicity and acronecrosis by aprotinin. Br.J. Exp. Path., 58: 260. GRASSO, P., SHARRATT, M., CARPANINI, F.M.B., & GANGOLLI, S.D. (1973) Studies on carrageenan and large-bowel ulceration in mammals. Fd. Cosmet. Toxicol, 11: 555. GRASSO, P., GANGOLLI, S.D., BUTTERWORTH, K.R., & WRIGHT, M.G. (1975) Studies on degraded carrageenan in rats and guinea pigs. Fd. Cosmet. Toxicol., 13: 195. HWANG, U.K. & CONNORS, N.A. (1974) Investigation of the toxic and teratogenic effects of GRAS substances to the developing chicken embryo. Unpublished report by St. Louis University School of Medicine, submitted from United States Food and Drug Administration to the WHO. JECFA (1974) Toxicological evaluation of some food additives including anticaking agents, antimicrobials, antioxidants, emulsifiers and thickening agents. WHO Food Additive Series, No. 5. JOINT FAO/WHO EXPERT COMMITTEE ON FOOD ADDITIVES (1974) Toxicological evaluation of some food additives including anticaking agents, antimicrobials, antioxidants, emulsifiers and thickening agents. FAO Nutrition Meetings Report Series, No. 53A, Food and Agriculture Organization of the United Nations, Rome, p. 386. KAWAURA, A., SHIBATA, M., TOGEI, K., & OTSUKA, H. (1982) Effect of dietary degraded carrageenan on intestinal dihydrochloride. Tokushima J. Exp. Med., 9: 125. MANKES, R. & ABRAHAM, R. (1975) Lysosomal dysfunction in colonic, submucosal macrophages of Rhesus monkeys caused by degraded iota carrageenan (38996). Proc. Soc. Exp. Biol. Med., 150: 166. MANKES, R.F. (1977) Safety evaluation of Iridaea carrageenans in the rat including a study of the mechanism of liver atrophy. Thesis. Unpublished. Albany Medical College. McGILL, H.C., Jr., McMAHAN, C.A., WIGODSKY, H.S., & SPRINZ, H. (1977) Carrageenan in formula and infant baboon development. Gastroenterology, 73; 512. NICKLIN, S. & MILLER, K. (1983) Persorption of carrageenan: uptake, distribution and immunological implications. The toxicologist, 3(1); 228. OCHUBA, G.U. & VON RIESEN, V.L. (1980) Fermentation of polysaccharides by Klebsielleae and other facultative bacilli. Appl. Environ. Microbiol., 39(5): 988. ONDERDONK, A.B., FRANKLIN, M.L., & CISNEROS, R.L. (1981) Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microflora. Infection Immunity, 225. OOHASHI, Y., ISHIOKA, T., WAKABAYASHI, K., & KUWABARA, N. (1981) A study on carcinogenesis induced by degraded carrageenan arising from squamous metaplasia of the rat colorectum. Cancer Lett., 14: 267. PITTMAN, K.A., GOLBERG, L., & COULSTON, F. (1976) Carrageenan; The effect of molecular weight and polymer type on its uptake, excretion and degradation in animals. Fd. Cosmet. Toxicol., 14: 85. REDDY, B.S., WATANABE, K., & SHEINFIL, A. (1980) Effect of dietary wheat bran, alfalfa, pectin and carrageenan on plasma cholesterol and fecal bile acid and neutral sterol excretion in rats. J. Nutrit., 110; 1247. ROVASIO, R.A. & MONIS, B. (1980) Lethal and teratogenic effects of lambda carrageenan, a food additive, on the development of the chick embryo. Toxicology Pathology, 8(1): 14. RUSTIA, M., SHUBIK, P., & PATIL, K. (1980) Lifespan carcinogenicity tests with native carrageenan in rats and hamsters. Cancer Letters, 11(1): 1. STANCIOFF, D.J. & RENN, D.W. (1975) Physiological effects of carrageenan. American Chemical Society. Symposium Series, 15. THOMSON, A.W. & WHlTING, P.H. (1981) A comparative study of renal and hepatic function in Sprague-Dawley rats following systemic injection of purified carrageenan (kappa, lambda and iota). Br. J. Exp. Path., 62: 207. TOMARELLI, R.M., TUCKER, W.D., Jr., BAUMANN, L.M., SAVINI, S., & WEABER, J.R. (1974) Nutritional quality of processed milk containing carrageenan. J. Agric. Food Chem., 22(5): 819. UDALL, J.N., HARMATZ, P., VACHINO, G., GALDABINI, J., & WALKER, W.A. (1981) Intestinal transport and liver uptake of a food additive present in infant formulas. Pediatric Res., 15: 549. VORHEES, C.V., BUTCHER, R.E., BRUNNER, R.L., & SOBOTKA, T.J. (1979) A developmental test battery for neurobehavioral toxicity in rats: A preliminary analysis using monosodium glutamate, calcium carrageenan and hydroxyurea. Toxicol. Appl. Pharmacol., 50: 267. WAKABAYASHI, K., INAGAKI, T., FUJIMOTO, Y., & FUKUDA, Y. (1978) Induction by degraded carrageenan of colorectal tumors in rats. Cancer Letters, 4; 171. WAKABAYASHI, K., FUJIMOTO, Y., OOHASAHI, Y., KUWAHARA, N., & FUKUDA, Y. (1979) Induction of colorectal tumors and its early lesions by degraded carrageenan in rats. In "Naturally Occurring Carcinogens-mutagens and Modulators of Carcinogenesis", E.C. Miller et al. (eds), Baltimore, University Park Press, p. 127. WATANABE, K., REDDY, B.S., WONG, C.Q., & WEISBURGER, J.H. (1978) Effect of dietary undegraded carrageenan on colon carcinogenesis in F344 rats treated with azoxymethane or methylnitrosourea. Cancer Res., 38: 4427. WATT, J. & MARCUS, R. (1971) Carrageenan-induced ulceration of the large intestine in the guinea pig. Gut, 12: 164.
See Also: Toxicological Abbreviations Carrageenan and furcellaran (FAO Nutrition Meetings Report Series 46a) Carrageenan and Furcellaran (WHO Food Additives Series 5)